Publication:
Interferon Induced Focal Segmental Glomerulosclerosis.

dc.contributor.authorKayar, Yusuf
dc.contributor.authorBayram Kayar, Nuket
dc.contributor.authorAlpay, Nadir
dc.contributor.authorHamdard, Jamshid
dc.contributor.authorEkinci, Iskender
dc.contributor.authorEmegil, Sebnem
dc.contributor.authorBag Soydas, Rabia
dc.contributor.authorBaysal, Birol
dc.date.accessioned2023-05-16T16:13:37Z
dc.date.available2023-05-16T16:13:37Z
dc.description.abstractBehçet's disease is an inflammatory disease of unknown etiology which involves recurring oral and genital aphthous ulcers and ocular lesions as well as articular, vascular, and nervous system involvement. Focal segmental glomerulosclerosis (FSGS) is usually seen in viral infections, immune deficiency syndrome, sickle cell anemia, and hyperfiltration and secondary to interferon therapy. Here, we present a case of FSGS identified with kidney biopsy in a patient who had been diagnosed with Behçet's disease and received interferon-alpha treatment for uveitis and presented with acute renal failure and nephrotic syndrome associated with interferon.
dc.identifier.pubmed27847659
dc.identifier.urihttps://hdl.handle.net/20.500.12645/38109
dc.language.isoen
dc.titleInterferon Induced Focal Segmental Glomerulosclerosis.
dspace.entity.typePublication
local.indexed.atPubMed

Files